Compare RANI & JRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RANI | JRSH |
|---|---|---|
| Founded | 2012 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.6M | 68.8M |
| IPO Year | 2021 | 2017 |
| Metric | RANI | JRSH |
|---|---|---|
| Price | $0.54 | $6.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $7.20 | $6.50 |
| AVG Volume (30 Days) | ★ 495.4K | 107.2K |
| Earning Date | 11-17-2026 | 11-10-2026 |
| Dividend Yield | N/A | ★ 3.41% |
| EPS Growth | 57.14 | ★ 485.71 |
| EPS | N/A | ★ 0.13 |
| Revenue | $1,633,000.00 | ★ $166,263,870.00 |
| Revenue This Year | $283.19 | $14.07 |
| Revenue Next Year | $5.99 | $7.46 |
| P/E Ratio | ★ N/A | $44.69 |
| Revenue Growth | ★ 58.85 | 14.03 |
| 52 Week Low | $0.55 | $2.85 |
| 52 Week High | $2.16 | $6.67 |
| Indicator | RANI | JRSH |
|---|---|---|
| Relative Strength Index (RSI) | 31.80 | 55.18 |
| Support Level | N/A | $4.37 |
| Resistance Level | $0.85 | $6.67 |
| Average True Range (ATR) | 0.04 | 0.23 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 17.67 | 68.36 |
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.